13F HOLDINGS REPORT
Birchview Capital, LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001618205-25-000009
Total Value
$100.7M
Positions
71
Other Managers
0
Confidential Omitted
No
Holdings (71)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 323,358 | $15.0M | 14.86% |
| 2 | KLA CORPORATION | KLAC | 15,848 | $14.2M | 14.10% |
| 3 | CORCEPT THERAPEUTICS INC | CORT | 67,200 | $4.9M | 4.90% |
| 4 | OVINTIV INC | OVV | 107,500 | $4.1M | 4.06% |
| 5 | ACADIA PHARMACEUTICALS INC | ACAD | 187,800 | $4.1M | 4.02% |
| 6 | NEUROCRINE BIOSCIENCES INC | NBIX | 30,940 | $3.9M | 3.86% |
| 7 | PHREESIA INC | PHR | 114,700 | $3.3M | 3.24% |
| 8 | PROTHENA CORP PLC | PRTA | 451,019 | $2.7M | 2.72% |
| 9 | PROTAGONIST THERAPEUTICS INC | PTGX | 48,000 | $2.7M | 2.63% |
| 10 | STOKE THERAPEUTICS INC | STOK | 210,000 | $2.4M | 2.37% |
| 11 | ELUTIA INC | ELUT | 1,159,059 | $2.3M | 2.28% |
| 12 | CASTLE BIOSCIENCES INC | CSTL | 110,600 | $2.3M | 2.24% |
| 13 | QUIDELORTHO CORP | QDEL | 72,548 | $2.1M | 2.08% |
| 14 | EQT CORPORATION | EQT | 34,619 | $2.0M | 2.01% |
| 15 | HARROW HEALTH INC | HROW | 60,000 | $1.8M | 1.82% |
| 16 | NOVOCURE LTD | NVCR | 101,000 | $1.8M | 1.79% |
| 17 | AXOGEN INC | AXGN | 161,000 | $1.7M | 1.73% |
| 18 | BIODESIX INC | BDSX | 5,736,113 | $1.6M | 1.61% |
| 19 | TRAVERE THERAPEUTICS INC | TVTX | 103,000 | $1.5M | 1.51% |
| 20 | FOGHORN THERAPEUTICS INC | FHTX | 310,930 | $1.5M | 1.45% |
| 21 | ALKERMES PLC | ALKS | 50,000 | $1.4M | 1.42% |
| 22 | MASIMO CORP | MASI | 8,280 | $1.4M | 1.38% |
| 23 | UNIQURE NV | QURE | 98,697 | $1.4M | 1.37% |
| 24 | UNITED THERAPEUTICS CORP | UTHR | 4,250 | $1.2M | 1.21% |
| 25 | DOCGO INC | DCGO | 764,062 | $1.2M | 1.19% |
| 26 | TREACE MEDICAL CONCEPTS INC | 89455T109 | 176,947 | $1.0M | 1.03% |
| 27 | SOLID BIOSCIENCES INC | SLDB | 178,768 | $870,600 | 0.86% |
| 28 | KINIKSA PHARMACEUTICALS LTD | KNSA | 30,000 | $830,100 | 0.82% |
| 29 | FREEPORT-MCMORAN CL-B | FCX | 18,033 | $781,737 | 0.78% |
| 30 | KALVISTA PHARMACEUTICALS INC | KALV | 67,000 | $757,435 | 0.75% |
| 31 | STRUCTURE THERAPEUTICS INC | GPCR | 36,000 | $746,640 | 0.74% |
| 32 | APOGEE THERAPEUTICS INC | APGE | 16,000 | $694,880 | 0.69% |
| 33 | OUTSET MEDICAL INC | OM | 34,584 | $664,359 | 0.66% |
| 34 | XENON PHARMACEUTICALS INC | XENE | 21,000 | $657,300 | 0.65% |
| 35 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 18,000 | $654,480 | 0.65% |
| 36 | AXSOME THERAPEUTICS INC | AXSM | 6,000 | $626,340 | 0.62% |
| 37 | OLEMA PHARMACEUTICALS INC | OLMA | 134,000 | $570,840 | 0.57% |
| 38 | SCHOLAR ROCK HOLDING CORP | SRRK | 16,000 | $566,720 | 0.56% |
| 39 | INTELLIA THERAPEUTICS INC | NTLA | 60,000 | $562,800 | 0.56% |
| 40 | ORTHOPEDIATRICS CORP | KIDS | 26,000 | $558,480 | 0.55% |
| 41 | IMMUNOME INC | IMNM | 60,000 | $558,000 | 0.55% |
| 42 | XENCOR INC | XNCR | 70,000 | $550,200 | 0.55% |
| 43 | HALOZYME THERAPEUTICS INC | HALO | 10,000 | $520,200 | 0.52% |
| 44 | PACIFIC BIOSCIENCES CALIF INC | 69404D108 | 400,000 | $496,000 | 0.49% |
| 45 | INHIBRX BIOSCIENCES INC | INBX | 32,110 | $458,210 | 0.46% |
| 46 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 8,000 | $377,600 | 0.37% |
| 47 | ALPHATEC HOLDINGS INC | ATEC | 33,000 | $366,300 | 0.36% |
| 48 | BIOCRYST PHARMACEUTICALS INC | BCRX | 40,000 | $358,400 | 0.36% |
| 49 | BLUEPRINT MEDICINES CORP | 09627Y109 | 2,700 | $346,086 | 0.34% |
| 50 | CYTOKINETICS INC | CYTK | 10,000 | $330,400 | 0.33% |
| 51 | CANDEL THERAPEUTICS INC | CADL | 60,000 | $303,600 | 0.30% |
| 52 | TELA BIO INC | TELA | 155,000 | $300,700 | 0.30% |
| 53 | COGENT BIOSCIENCES INC | COGT | 40,000 | $287,200 | 0.29% |
| 54 | WAVE LIFE SCIENCES LTD | WVE | 40,300 | $261,950 | 0.26% |
| 55 | 10X GENOMICS INC | TXG | 22,000 | $254,760 | 0.25% |
| 56 | APELLIS PHARMACEUTICALS INC | APLS | 14,000 | $242,340 | 0.24% |
| 57 | PHATHOM PHARMACEUTICALS INC | PHAT | 25,000 | $239,750 | 0.24% |
| 58 | BRIDGEBIO PHARMA INC | BBIO | 5,000 | $215,900 | 0.21% |
| 59 | NEUROPACE INC | NPCE | 16,442 | $183,164 | 0.18% |
| 60 | GOSSAMER BIO INC | GOSS | 138,176 | $169,956 | 0.17% |
| 61 | AMICUS THERAPEUTICS INC | FOLD | 28,000 | $160,440 | 0.16% |
| 62 | ZENAS BIOPHARMA INC | ZBIO | 16,500 | $159,885 | 0.16% |
| 63 | CULLINAN THERAPEUTICS INC | CGEM | 20,000 | $150,600 | 0.15% |
| 64 | KARYOPHARM THERAPEUTICS INC | KPTI | 27,985 | $120,615 | 0.12% |
| 65 | APPLIED THERAPEUTICS INC | 03828A101 | 280,000 | $87,108 | 0.09% |
| 66 | VENTYX BIOSCIENCES INC | 92332V107 | 28,800 | $61,632 | 0.06% |
| 67 | INFLARX NV | IFRX | 50,000 | $39,500 | 0.04% |
| 68 | APTEVO THERAPEUTICS INC | APVO | 10,000 | $30,500 | 0.03% |
| 69 | ALUMIS INC | ALMS | 10,000 | $30,000 | 0.03% |
| 70 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 17,000 | $19,720 | 0.02% |
| 71 | ACCELERATE DIAGNOSTICS INC | 00430H102 | 325,239 | $2,082 | 0.00% |